|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
6
|
|
pubmed:dateCreated |
2006-5-29
|
|
pubmed:abstractText |
Linezolid is being used increasingly for life-threatening vancomycin-resistant infections in critically ill patients. Limited data suggest that linezolid is cleared by intermittent hemodialysis. However, information on clearance of linezolid by continuous renal replacement therapy is limited. A patient undergoing continuous venovenous hemodiafiltration (CVVHDF) was evaluated to determine linezolid clearance through CVVHDF.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Jun
|
|
pubmed:issn |
1523-6838
|
|
pubmed:author |
|
|
pubmed:issnType |
Electronic
|
|
pubmed:volume |
47
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
e83-6
|
|
pubmed:dateRevised |
2010-11-18
|
|
pubmed:meshHeading |
pubmed-meshheading:16731287-Acetamides,
pubmed-meshheading:16731287-Acute Kidney Injury,
pubmed-meshheading:16731287-Adult,
pubmed-meshheading:16731287-Anti-Bacterial Agents,
pubmed-meshheading:16731287-Anti-Infective Agents,
pubmed-meshheading:16731287-Drug Resistance, Bacterial,
pubmed-meshheading:16731287-Fasciitis, Necrotizing,
pubmed-meshheading:16731287-Hemofiltration,
pubmed-meshheading:16731287-Humans,
pubmed-meshheading:16731287-Male,
pubmed-meshheading:16731287-Metabolic Clearance Rate,
pubmed-meshheading:16731287-Oxazolidinones,
pubmed-meshheading:16731287-Time Factors,
pubmed-meshheading:16731287-Urinary Tract Infections,
pubmed-meshheading:16731287-Vancomycin
|
|
pubmed:year |
2006
|
|
pubmed:articleTitle |
Clearance of linezolid via continuous venovenous hemodiafiltration.
|
|
pubmed:affiliation |
University of Toledo College of Pharmacy, OH, USA. lmauro@utnet.utoledo.edu
|
|
pubmed:publicationType |
Journal Article,
Case Reports,
Research Support, Non-U.S. Gov't
|
